SenoVue
It is currently in the clinical stage and is scheduled to be commercialized in 2024.
| 1. Region Selection | 2. Scanning target areas | 3. DICOM 1) Image Reading | 4. PACS 2) Scan Result Reporting | |||||
|
|
|
|
|||||
|
1) DICOM(Digital Imaging and Communications in Medicine) 2) PACS: Picture Archiving and Communication |
||||||||
|
01 |
Technical excellence Technology to replace the existing mammoth market |
|
|
02 |
High-Precision Biopsy-level diagnostic accuracy |
|
|
03 |
Quantitative & Intuitive Malignancy index & Color image |
|
|
04 |
Safe & Painless Non-radiative & non-invasive |
|
|
05 |
Low Cost & Usability
Low BOM(Bill of Materials) |
It is currently in the clinical stage and is scheduled to be commercialized in 2025.
| 1. Region Selection |
|
|
| 2. Scanning target areas |
|
|
| 3. DICOM 1) Image Reading |
|
|
| 4. PACS 2) Scan Result Reporting |
|
|
|
1) DICOM(Digital Imaging and Communications in Medicine) 2) PACS: Picture Archiving and Communication |
for data-driven training
|
|
|
01 |
|
Technical excellence Technology to replace the existing mammoth market |
|
02 |
|
High-Precision Biopsy-level diagnostic accuracy |
|
03 |
|
Quantitative & Intuitive Malignancy index & Color image |
|
04 |
|
Safe & Painless Non-radiative & non-invasive |
|
05 |
|
Low Cost & Usability Low BOM(Bill of Materials) & Easy to install & Hospital's diverse usability |